Huffman, B.M.; Ellis, H.; Jordan, A.C.; Freed-Pastor, W.A.; Perez, K.; Rubinson, D.A.; Sethi, N.; Singh, H.; Surana, R.; Wolpin, B.M.;
et al. Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma. Cancers 2022, 14, 6223.
https://doi.org/10.3390/cancers14246223
AMA Style
Huffman BM, Ellis H, Jordan AC, Freed-Pastor WA, Perez K, Rubinson DA, Sethi N, Singh H, Surana R, Wolpin BM,
et al. Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma. Cancers. 2022; 14(24):6223.
https://doi.org/10.3390/cancers14246223
Chicago/Turabian Style
Huffman, Brandon M., Haley Ellis, Alexander C. Jordan, William A. Freed-Pastor, Kimberly Perez, Douglas A. Rubinson, Nilay Sethi, Harshabad Singh, Rishi Surana, Brian M. Wolpin,
and et al. 2022. "Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma" Cancers 14, no. 24: 6223.
https://doi.org/10.3390/cancers14246223
APA Style
Huffman, B. M., Ellis, H., Jordan, A. C., Freed-Pastor, W. A., Perez, K., Rubinson, D. A., Sethi, N., Singh, H., Surana, R., Wolpin, B. M., Aguirre, A. J., & Cleary, J. M.
(2022). Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma. Cancers, 14(24), 6223.
https://doi.org/10.3390/cancers14246223